Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11345702
PGDH inhibitors and methods of making and using
granted -
US 11339193
CDP protein secretion inhibitors
granted -
US 11339150
Benzimidazole compounds as HDAC6 inhibitors
granted -
US 11337941
Inhibitors and their uses
granted -
US 11339160
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted -
US 11331332
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
granted -
US 11332470
CXCR4 inhibitors and uses thereof
granted -
US 11331286
Inhibitors and their uses
granted -
US 11332451
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 11332540
Use of Circ-CDH1 inhibitors
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted -
US 11325938
CD73 inhibitors
granted -
US 11325936
Sialidase inhibitors and preparation thereof
granted -
US 11319302
PRC1 inhibitors and methods of treatment therewith
granted -
US 11311517
Combination of small molecule CD-47 inhibitors with other anti-cancer agents
granted -
US 11311624
Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds
granted -
US 11306088
CXCR4 inhibitors and uses thereof
granted -
US 11306095
Use of pteridinone derivative serving as EGFR inhibitor
granted -
US 11306098
Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
granted -
US 11299492
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 11291659
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 11291663
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11292847
Methods for treating atopic dermatitis by administering an IL-4R inhibitor
granted -
US 11286307
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
granted